🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a clinical trial involving two medicines called piperaquine (P...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2022-02-14
Trial ID
NCT05160363
Treatments Being Tested
This is a phase Ⅰ，single-center, randomized, double-blinded, placebo-contro...
Status
Completed
Location
China-Japan Friendship Hospital
Start Date
2019-03-01
Trial ID
NCT04119947
Treatments Being Tested
This study is to evaluate the safety, tolerability, and PK of SR750 in heal...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2021-10-29
Trial ID
NCT05083468
Treatments Being Tested
ARQ 197 or placebo in combination with irinotecan and cetuximab in particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-26
Trial ID
NCT01075048
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of NPC-...
Status
Completed
Location
Fujita Health University Hospital
Start Date
2022-06-01
Trial ID
NCT05495425
Treatments Being Tested
This purpose of this study is to assess the effect of febuxostat, once dail...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01078389
Treatments Being Tested
A study to investigate the safety and tolerability of both single and multi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-12
Trial ID
NCT00459550
Treatments Being Tested
Colchicine has been widely used as an anti-gout medicine in the past decade...
Status
Not Yet Recruiting
Location
Mengmei Li
Start Date
2022-12-06
Trial ID
NCT05175274
Treatments Being Tested
The purpose of this global, multicenter, Phase 3 study is to evaluate the e...
Status
Recruiting
Location
Inland Rheumatology Clinical Trials, Inc.
Start Date
2026-04-01
Trial ID
NCT07355218
Treatments Being Tested
This is a 24-week randomized, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
AZ Allergy & Immunology Research
Start Date
2018-11-27
Trial ID
NCT03781804
Treatments Being Tested